|
UFM1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.18369808083708E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.12610000213564E-08 |
| Normal-vs-Stage2 |
2.48189999996207E-06 |
| Normal-vs-Stage3 |
1.22230003896107E-11 |
| Normal-vs-Stage4 |
1.55309987093233E-10 |
| Stage1-vs-Stage2 |
4.024600E-01 |
| Stage1-vs-Stage3 |
6.276800E-03 |
| Stage1-vs-Stage4 |
2.577600E-02 |
| Stage2-vs-Stage3 |
3.175800E-01 |
| Stage2-vs-Stage4 |
3.302200E-01 |
| Stage3-vs-Stage4 |
9.204400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.81041856453612E-12 |
| Normal-vs-AfricanAmerican |
3.224200E-03 |
| Normal-vs-Asian |
2.84149999996153E-06 |
| Caucasian-vs-AfricanAmerican |
6.035400E-01 |
| Caucasian-vs-Asian |
4.273200E-01 |
| AfricanAmerican-vs-Asian |
9.587400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.93500002079838E-10 |
| Normal-vs-Female |
6.54699960911387E-10 |
| Male-vs-Female |
3.010000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.34840000054481E-07 |
| Normal-vs-Age(41-60Yrs) |
2.2492996354373E-10 |
| Normal-vs-Age(61-80Yrs) |
9.82389725123767E-11 |
| Normal-vs-Age(81-100Yrs) |
4.567400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.237700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.138010E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.502800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.701000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.620600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.724400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.828180E-01 |
| Classical-VS-Follicular |
6.037200E-01 |
| Classical-VS-Other |
3.689000E-01 |
| Classical-VS-Normal |
4.65069982524824E-10 |
| Tall-VS-Follicular |
1.171600E-01 |
| Tall-VS-Other |
8.231600E-01 |
| Tall-VS-Normal |
1.37040000014466E-07 |
| Follicular-VS-Other |
3.939600E-01 |
| Follicular-VS-Normal |
1.84849000000042E-05 |
| Other-VS-Normal |
1.341090E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.16660039803673E-10 |
| Normal-vs-N1 |
1.28349999961586E-07 |
| N0-vs-N1 |
9.180800E-01 |
|
|
